Creative Planning Adverum Biotechnologies, Inc. Transaction History

Creative Planning

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 05, 2020	SELL	$7.98 - $16.32 $167,580 - $342,720	-21,000 Closed	0 $0
Q3 2019 Nov 01, 2019	BUY	$5.24 - $15.89 $5,240 - $15,890	1,000 Added 5.0%	21,000 $114,000
Q4 2018 Feb 01, 2019	SELL	$2.87 - $5.92 $8,810 - $18,174	-3,070 Reduced 13.31%	20,000 $63,000
Q3 2018 Oct 25, 2018	BUY	$4.5 - $7.6 $900 - $1,520	200 Added 0.87%	23,070 $140,000
Q2 2018 Jul 20, 2018	BUY	$5.3 - $6.9 $52,666 - $68,565	9,937 Added 76.83%	22,870 $121,000
Q1 2018 Apr 18, 2018	BUY	$3.65 - $7.95 $47,205 - $102,817	12,933 New	12,933 $75,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $589M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.